352 related articles for article (PubMed ID: 24787905)
21. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
Zitzmann M
Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men.
Walsh S; Zmuda JM; Cauley JA; Shea PR; Metter EJ; Hurley BF; Ferrell RE; Roth SM
J Appl Physiol (1985); 2005 Jan; 98(1):132-7. PubMed ID: 15377647
[TBL] [Abstract][Full Text] [Related]
24. [Polymorphism of AR gene CAG copy number and late-onset hypogonadism in males].
Liang GQ; Wu M; Wang B; Liu ZY; Yao WL; Li Z; Sun YH
Zhonghua Nan Ke Xue; 2012 Sep; 18(9):797-802. PubMed ID: 23193666
[TBL] [Abstract][Full Text] [Related]
25. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
26. The interaction of serum testosterone levels and androgen receptor CAG repeat polymorphism on the risk of erectile dysfunction in aging Taiwanese men.
Liu CC; Lee YC; Tsai VF; Cheng KH; Wu WJ; Bao BY; Huang CN; Yeh HC; Tsai CC; Wang CJ; Huang SP
Andrology; 2015 Sep; 3(5):902-8. PubMed ID: 26216079
[TBL] [Abstract][Full Text] [Related]
27. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.
Ferlin A; Schipilliti M; Vinanzi C; Garolla A; Di Mambro A; Selice R; Lenzi A; Foresta C
J Clin Endocrinol Metab; 2011 Apr; 96(4):E739-45. PubMed ID: 21270324
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor CAG repeats and body composition among Ariaal men.
Campbell BC; Gray PB; Eisenberg DT; Ellison P; Sorenson MD
Int J Androl; 2009 Apr; 32(2):140-8. PubMed ID: 18042182
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
30. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men.
Zitzmann M; Gromoll J; von Eckardstein A; Nieschlag E
Diabetologia; 2003 Jan; 46(1):31-9. PubMed ID: 12637980
[TBL] [Abstract][Full Text] [Related]
31. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF
Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136
[TBL] [Abstract][Full Text] [Related]
32. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
[TBL] [Abstract][Full Text] [Related]
33. The role of the CAG repeat androgen receptor polymorphism in andrology.
Zitzmann M
Front Horm Res; 2009; 37():52-61. PubMed ID: 19011288
[TBL] [Abstract][Full Text] [Related]
34. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men.
Skjaerpe PA; Giwercman YL; Giwercman A; Svartberg J
Int J Androl; 2010 Jun; 33(3):500-6. PubMed ID: 19207614
[TBL] [Abstract][Full Text] [Related]
36. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
[TBL] [Abstract][Full Text] [Related]
37. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor GGC repeat might be more involved than CAG repeat in the regulation of the metabolic profile in men.
Tirabassi G; Cutini M; Beltrami B; Delli Muti N; Lenzi A; Balercia G
Intern Emerg Med; 2016 Dec; 11(8):1067-1075. PubMed ID: 27251588
[TBL] [Abstract][Full Text] [Related]
39. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
Stanworth RD; Kapoor D; Channer KS; Jones TH
Clin Endocrinol (Oxf); 2011 May; 74(5):624-30. PubMed ID: 21470285
[TBL] [Abstract][Full Text] [Related]
40. Association between repeat length of exon 1 CAG microsatellite in the androgen receptor and bone density in men is modulated by sex hormone levels.
Stiger F; Brändström H; Gillberg P; Melhus H; Wolk A; Michaelsson K; Kindmark A
Calcif Tissue Int; 2008 Jun; 82(6):427-35. PubMed ID: 18484228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
